Non-alcoholic steatohepatitis-associated hepatic fibrosis and hepatocellular carcinoma in a combined mouse model of genetic modification and dietary challenge.

Amano, Yuichiro; Shimizu, Fumi; Yasuno, Hironobu; Harada, Ayako; Tsuchiya, Shuntarou; Isono, Osamu; Nagabukuro, Hiroshi; Tozawa, Ryuichi

Amano, Yuichiro; Shimizu, Fumi; Yasuno, Hironobu; Harada, Ayako; Tsuchiya, Shuntarou; Isono, Osamu; Nagabukuro, Hiroshi; Tozawa, Ryuichi.

Affiliation

Amano Y; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
Shimizu F; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
Yasuno H; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
Harada A; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
Tsuchiya S; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
Isono O; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
Nagabukuro H; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
Tozawa R; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.

Hepatol Res ; 47(1): 103-115, 2017 Jan.

Article de En | MEDLINE | ID: mdl-26992446

Mots clés

CDAA diet; LDL receptor knockout mouse; adenoma; carcinoma; hepatic fibrosis; non-alcoholic steatohepatitis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: Hepatol Res Année: 2017 Type de document: Article Pays d'affiliation: Japon Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google